ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

First-in-Human Dose-Escalation Study of the First-in-Class PDE3A-SLFN12 Complex Inducer BAY 2666605 in Patients with Advanced Solid Tumors Coexpressing SLFN12 and PDE3A.

Kyriakos P Papadopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.